A Safety Net That May Not Be So Safe: Elan Sues Biogen Over J&J Deal

 
• By Wendy Diller

Elan's new deal with J&J over its key Alzheimer's assets runs into a brick wall: Biogen.

More from Archive

More from Pink Sheet